AMBARELLA INC (AMBA)

KYG037AX1015 - Common Stock

43.09  +0.79 (+1.87%)

After market: 43.09 0 (0%)

Fundamental Rating

4

Overall AMBA gets a fundamental rating of 4 out of 10. We evaluated AMBA against 107 industry peers in the Semiconductors & Semiconductor Equipment industry. While AMBA has a great health rating, there are worries on its profitability. AMBA is valied quite expensively at the moment, while it does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

AMBA had negative earnings in the past year.
In the past year AMBA had a positive cash flow from operations.
AMBA had negative earnings in each of the past 5 years.
Each year in the past 5 years AMBA had a positive operating cash flow.

1.2 Ratios

AMBA's Return On Assets of -25.76% is on the low side compared to the rest of the industry. AMBA is outperformed by 83.02% of its industry peers.
The Return On Equity of AMBA (-30.26%) is worse than 74.53% of its industry peers.
Industry RankSector Rank
ROA -25.76%
ROE -30.26%
ROIC N/A
ROA(3y)-12.99%
ROA(5y)-11.58%
ROE(3y)-15.29%
ROE(5y)-13.69%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AMBA's Gross Margin of 60.77% is amongst the best of the industry. AMBA outperforms 83.02% of its industry peers.
In the last couple of years the Gross Margin of AMBA has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for AMBA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.53%
GM growth 5Y0.38%

8

2. Health

2.1 Basic Checks

AMBA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AMBA has been increased compared to 1 year ago.
The number of shares outstanding for AMBA has been increased compared to 5 years ago.
AMBA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

AMBA has an Altman-Z score of 10.28. This indicates that AMBA is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 10.28, AMBA belongs to the top of the industry, outperforming 82.08% of the companies in the same industry.
There is no outstanding debt for AMBA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.28
ROIC/WACCN/A
WACC11.7%

2.3 Liquidity

AMBA has a Current Ratio of 3.38. This indicates that AMBA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of AMBA (3.38) is comparable to the rest of the industry.
AMBA has a Quick Ratio of 3.03. This indicates that AMBA is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 3.03, AMBA is doing good in the industry, outperforming 62.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.38
Quick Ratio 3.03

4

3. Growth

3.1 Past

AMBA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -173.87%.
Looking at the last year, AMBA shows a very negative growth in Revenue. The Revenue has decreased by -32.94% in the last year.
Measured over the past years, AMBA shows a decrease in Revenue. The Revenue has been decreasing by -0.12% on average per year.
EPS 1Y (TTM)-173.87%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-204.35%
Revenue 1Y (TTM)-32.94%
Revenue growth 3Y0.52%
Revenue growth 5Y-0.12%
Revenue growth Q2Q-38.04%

3.2 Future

The Earnings Per Share is expected to grow by 43.00% on average over the next years. This is a very strong growth
AMBA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.71% yearly.
EPS Next Y-6.02%
EPS Next 2Y35.97%
EPS Next 3Y57.11%
EPS Next 5Y43%
Revenue Next Year8.94%
Revenue Next 2Y18.2%
Revenue Next 3Y25.07%
Revenue Next 5Y26.71%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

AMBA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMBA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

AMBA's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 250.46
EV/EBITDA N/A

4.3 Compensation for Growth

AMBA's earnings are expected to grow with 57.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.97%
EPS Next 3Y57.11%

0

5. Dividend

5.1 Amount

No dividends for AMBA!.
Industry RankSector Rank
Dividend Yield N/A

AMBARELLA INC

NASDAQ:AMBA (4/26/2024, 7:00:00 PM)

After market: 43.09 0 (0%)

43.09

+0.79 (+1.87%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.76B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.76%
ROE -30.26%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 60.77%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.38
Quick Ratio 3.03
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-173.87%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-6.02%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-32.94%
Revenue growth 3Y0.52%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y